Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN Symposium 2018 /
Implementing precision medicine in oncology: The IMPACT trials

25th - 26th Jun 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.07.18
Views: 1260

Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA

Prof Tsimberidou speaks with ecancer at the 2018 WIN symposium about her role in the IMPACT Clinical Trials at MD Anderson Center.

She begins by outlining the some of the challenges and how they will be overcome.

The IMPACT studies were designed to optimise treatment selection based on patient tumour molecular profiling, with 3,700 patients being analysed to date.

Prof Tsimberidou also spoke with ecancer at ASCO 2018

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation